GENE ONLINE|News &
Opinion
Blog

2021-08-24| R&D

Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?

by Isha Kapoor
Share To
Despite the availability of effective and inexpensive hormonal contraceptives, many women risk unintended pregnancies because of medical contraindications, or serious unpleasant or unbearable side-effects associated with the use of exogenous hormones.

A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.

GO Prime with only $1.49 now

LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top